Auditory neuropathy and newborn screenings


  • German Trinidad Ramos Hospital Universitario de Badajoz. Servicio de ORL, Badajoz, España
  • Gabriel Trinidad Ruiz Hospital Universitario de Badajoz. Servicio de ORL, Badajoz, España



auditory neuropathy, newborn screening


In the 2010 CODEPEH Recommendations, the discovery of all hearing loss is advised regardless of its etiology and severity. Auditory neuropathy can go unnoticed in programs based on the use of otoemissions as the first level of screening. However, there are very specific cases that can present this pathology and this allows its discovery provided that adequate criteria are followed in the programs based on otoemissions, as has been done in all of them. This work, in addition to describing this pathology in its etiological, pathophysiological, clinical, diagnostic and therapeutic aspects, specifies those antecedents that make us suspect, not only auditory neuropathy, but also retrocochlear lesions that, due to their own location, would not be detected by otoemissions. It is children who spend more than 5 days in PICU, those with toxoplasmosis, those who have had hyperbilirubinemia with exchange transfusion, and those with a family history of neurological processes, especially those with a history of Otof Gene disorders, who need to complete screening with auditory evoked potentials.


Download data is not yet available.

        Visibility and Altmetrics


Metrics Loading ...


Trinidad-Ramos G, et al. Recomendaciones de la Comisión para la Detección Precoz de la Hipoacusia (CODEPEH) para 2010. Acta Otorrinolaringol Esp. 2009.

Starr A, Picton TW, Sininger Y, Hood LJ, Berlin e1. Auditory neropathy. Braín 1996;119:741-3.

Trinidad G. Valoración de los criterios de riesgo de padecer hipoacusias a la vista de un programa de cribado universal

Wilson JMG, Junger G. Principles and practice of screening for disease. Public Health Papers 34. Geneva:World Health Organitation; 1968.

Seymour CA,Thomason MJ, Chalmers RA, et al. Newborn screening for inborn errors of metabolism: a systematic review. Health Technology Assessment. 1997;1:1-95.

Murray J, Cuckle H, Taylor G, et al. Screening for cystic fibrosis. Health Technology Assessment. 1999;3:1-104.

Davies SC, Cronin E, Gill M, et al. Screening for sickle cell disease and thalasemia: a systematic review with supplementary research. Health Technology Assessment. 2000;4:1-99.

Pandor A, Eastham J, Beverly C, et al. Clinical effectiveness and cost-effectiveness of neonatal screening for inborn errors of metabolism using tandem mass spectrometry: a systematic review. Health Technology Assessment. 2004;8:1-121.

Centers for Disease Control and Prevention. Newborn screening for cystic fibrosis: evaluation of benefits and risks and recommendations for state newborn programs.MMWR. 2004;53(RR-13).

González-Lamuño. Screening metabólico neonatal expandido Bol Pediatr 2008; 48: 329-331

Worthington DW, Peters JF. Quantificable hearing and no abr: paradox or error?. Ear Hear 1980;5:281-5

Kraus N, Ozdamar V, Stein L, Redd N. Absent auditory brain stem response: peripheral hearing loss or brain stem dysfunction? Laryngoscope 1984;94:400-6.

Tapia Me, Almenar A, Lirola A, Moro M. Neuropatía auditiva. An Esp Pedíatr 2000;53:399-404.

Morant A, Orotos M, García J, Pitarch M1, Marco J. Neuropatía auditiva en niños. Acta Otorrínolaríngol Esp 51:530-4.

Tapia Me. Neuropatía auditiva infantil. Auditio: revista electrónica de Audiología 2001;1:3-5.

Labella T. Rio M. Vaamonde P.Porto I.Lozano A. La neuropatía auditiva ORL-D PS 2002;29(5):216-222

Sheykholeslami K, Kaga K, Kaga M. An isolated and sporadic auditory neuropathy (auditory nerve disesase): report of five patines. J Laryngol Otol 2001;115:530-4

Cone-Wesson B, Rance G. Auditory Neuropathy: a brief review. Curr Opin Otolaryngol Head Neck Surg 2000; 8: 421-5.

Shapiro SM, Nakamura H. Bilirubin and the auditory system". J Perínatol 2001;21(sup 1):52-5.

Rance G. Auditory Neuropathy/Dys-synchrony and it's perceptual consequences. Trends Amplif 2005; 9: 1-43.

Rance G, Cone-Wesson B, Wunderlich J, Dowell R. Speech Perception And Cortical Event Related Potentials in Children with AuditoryNeuropathy. Ear Hear 2002; 23: 239-53.

Starr A, Sininger V, Winter M, Derebery MU, Ota S, Michalewki HU. Transient deafness due to temperature-sensitive auditory neuropathy. Ear Hear 1998; 19: 169-79.

Kovach MJ, Campbell K, Herman K, Waggoner B, Gelber D, Hughes LF, Kimonis VE. "Anticipation in a unique family with Charcot-Marie-Tooth syndrome and deafness: delineation of the clinical features and review of the literature". Am J Med Genet 2002;108:295-303. 24 Oysy e, Aslan 1, Basaran B, Baserer N. The site of the hearing loss in Refsum's disease. Int J Pedíatr Otorhínolaryngol 2001;61:129-34.

López-Bigas N, Olive M, Rabionet R, Ben-David O, Martínez- Matos, JA, Bravo O, Banchs 1, Volpini V, Gasparini P, Avraham KB, Ferrer 1, Arbones ML, Estivill X. Hum Mol Genet 2001;10:947-52.

Núñez-Batalla F, Carro-Fernandez P, Antuña-León ME, Gonzalez-Trelles T. Incidence of hypoacusia secondary to hyperbilirubinaemia in a universalneonatal auditory screening programme based on otoacoustic emissions and evoked auditory potentials. Acta Otorrinolaringol Esp 2008; 59: 108-1.

MCMahon CM, Patuzzi RB, Gibson WP, Sanli H. Frequencyspecific eletrocochleography indicates that presynaptic and postsynaptic mechanisms of auditory neuropathy exist. Ear Hear 2008; 29(3): 314-25.

Rance G. Auditory Neuropathy/Dyssynchrony and it's Perceptual Co nsequences. Trends Amplif 2005

(1): 1-43. 29 Sawada S, Mori N, Mount RJ, Harrison RV. Differential vulnerability of inner hair cell systems to chronic mild hypoxia and glutamate ototoxicity: insights into the cause of auditory neuropathy. J Otolaryngol 2001;30: 106-14.

Kraus N, Bradlow AR, eheatham MA, eunningham J, King eD, Koch DB, Nicol TG, Megee TJ, Stein LK, Writh BA. eonsecuences of neural asynchrony: a case of auditory neuropathy. J Assoc Res Otolaryngol 2000; 1:33-45.

Berlin CH, Morlet T, Hood L. Auditory Neuropathy / Dyssynchrony. Its diagnosis and management. Pediatr Clin N Am 2003; 50: 331-40.

Tlumak A. Electrophysiological Responses in individuals with Auditory Neuropathy. Semin Hear 2002; 183-191.

Berlin CH, Hood L, Morlet T, Wilensky D, ST John P, Montgomery E et al. Absent o elevated muscle reflex in the resence of normal Otoacoustic Emissions: A universal Finding in 136 cases of auditory neuropathy/Dyssynchrony. J Am Acad Audiol 2005; 16(8): 546-53.

Kaga M, Kon K, Uno A, Horiguchi T, Yoneyama H, 1nagaki M. Auditory perception in auditory neuropathy: clinical similarity with auditory verbal agnosia. Braín Dev 2002;24:197-202.

King AM, Purdy SC, Dillon H, Sharma M, Pearce W. Australian Hearing Protocols for the Audiological Management of Infants Who HaveAuditory Neuropathy. Australian and New Zealand Journal of Audiology 2005; 27: 69-77.

Vlastarakos PV, Nikolopoulos TP, Tavoulari E, Ppapacharalambous G, Korres S. Auditory neuropathy: Endocochlear lesion or temporal processing impairment? Implications for diagnosis and management. Int J Pediatr Otorhinolaryngol 2008; 72: 8: 1135-50.

Gallo J, Morales C, Sanchez N, Manrique M, Rodriguez M, Moreno MA Y COLS. Auditory neuropathy due to the Q829X mutation in the ene encoding otoferlin (OTOF) in an infant screened for newborn hearing impairment. Acta Otorrinolaringol Esp 2006; 57 (7): 333-5.

TlumakA. Electrophysiological Responses in individuals with Auditory Neuropathy. Semin Hear 2002; 183-191.

Gibson WP, Grahan JM. Editorial: 'auditory neuropathy' and cochlear implantation - myths and facts. Cochlear Implants Int 2008; 9 (1): 1-7.

Rance G, Barker EJ. Speech perception in children with auditory neuropathy/dyssynchrony managed with either hearing aids or cochlear implants. Otol Neurotol 2008; 29 (2): 5-6.

Portada Auditio.


2015-02-01 — Updated on 2021-09-15


How to Cite

Trinidad Ramos, G., & Trinidad Ruiz, G. (2021). Auditory neuropathy and newborn screenings. Auditio, 4(1), 3–8. (Original work published February 1, 2015)



e-journal of audiology (archive before 2021 only in Spanish)